Abstract:The successful implementation of stem cell therapy requires the development of imaging techniques to track transplanted stem cells in vivo and monitor their fate over time. Most in vivo imaging methods focus on providing information about the distribution and migration of transplanted stem cells, while monitoring their viability-crucial for optimizing therapy-remains undeveloped. Although a few in vivo imaging techniques have been developed for assessing the viability of transplanted stem cells, their applicability is restricted by limited penetration depth. To address this, magnetic resonance imaging (MRI) that is collaboratively utilized with tailored contrast agents has been explored to track the viability of transplanted stem cells without this limitation. However, currently available MRI contrast agents struggle with low accuracy in monitoring viability due to poor controllability or minimal signal change in response to cell death. Here, we present an extremely small iron oxide nanoparticles (ESIONPs)-based T1-T2 switchable MRI contrast agent (ESIONPs-GSH) designed to accurately detect cell apoptosis in response to elevated reactive oxygen species (ROS).Specifically, ESIONPs-GSH was obtained by modifying the surface of ESIONPs with ROS-sensitive glutathione (GSH) and amphipathic 3-((3-aminopropyl) dimethylammonio) propane-1-sulfonate (ADPS) molecules. The results demonstrate that ESIONPs-GSH is biocompatible, with negligible effects on the proliferation and differentiation of bone mesenchymal stem cells (BMSCs) post-labeling. Additionally, BMSCs labeled with ESIONPs-GSH exhibit T1 contrast; upon cell death, increasing cellular ROS oxidize GSH and induce cross-linking of ESIONPs-GSH, resulting in a switch to T2 contrast. Benefiting from the significantly contrasting signal following the T1-T2 contrast switch, ESIONPs-GSH allows for accurate assessment of the survival of BMSCs transplanted into the axillary regions of mice through MRI monitoring. ESIONPs-GSH enabled MRI can effectively track transplanted stem cell viability in vivo without penetration depth limitations, making it a promising tool for guiding stem cell-based therapies.

Self-assembled Dual-Modality Contrast Agents for Non-Invasive Stem Cell Tracking Via Near-Infrared Fluorescence and Magnetic Resonance Imaging.

Labeling Neural Stem Cells with Superparamagnetic Iron Oxide and MRI Tracking in Vitro and in Vivo

Self-assembled NIRF/MRI Dual-modality Contrast Agents for Rat Bone Stem Cell (RBMSC) Tracking

Magnetic Resonance Imaging of Iron Oxide-Labeled Human Embryonic Stem Cell-Derived Cardiac Progenitors.

Stem Cell Labeling With Superparamagnetic Iron Oxide Nanoparticles Using Focused Ultrasound And Magnetic Resonance Imaging Tracking

Superparamagnetic Iron Oxide Nanoparticles As MRI Contrast Agents for Non-invasive Stem Cell Labeling and Tracking

Stem cell tracking using effective self-assembled peptide-modified superparamagnetic nanoparticles.

Magnetic Labeling and Tracking of Cells Using Magnetodendrimers As MR Contrast Agent

A Positively Charged Small-Molecule T1 Magnetic Resonance Imaging Contrast Agent for Highly Efficient Labeling and Tracking Adipose Tissue-Derived Stem Cells

Labeling Stem Cells with A Near-Infrared Fluorescent Heptamethine Dye for Noninvasive Optical Tracking

Multifunctional upconversion nanoparticles for dual-modal imaging-guided stem cell therapy under remote magnetic control

Multimodality Molecular Imaging of Stem Cells Therapy for Stroke.

In Vivo MRI Tracking of Bone Mesenchymal Stem Cell Viability with a T1-T2 Switchable Contrast Agent

Nano Contrast Agents for Stem Cell Tracking in Stroke

Protamine functionalized single-walled carbon nanotubes for stem cell labeling and in vivo Raman/magnetic resonance/photoacoustic triple-modal imaging

Biocompatible Iron Oxide Nanoring-Labeled Mesenchymal Stem Cells: An Innovative Magnetothermal Approach for Cell Tracking and Targeted Stroke Therapy

Stem Cell Tracking with Optically Active Nanoparticles.

Gadolinium hybrid iron oxide nanocomposites for dual T 1 - and T 2 -weighted MR imaging of cell labeling.

A Cell Penetrating Peptide-Modified Magnetic/fluorescent Probe for in Vivo Tracking of Mesenchymal Stem Cells

Ligand-mediated Endocytosis of Nanoparticles in Neural Stem Cells: Implications for Cellular Magnetic Resonance Imaging

Superparamagnetic Iron Oxide Nanoparticles-Complexed Cationic Amylose for In Vivo Magnetic Resonance Imaging Tracking of Transplanted Stem Cells in Stroke